HK Stock MarketDetailed Quotes
06833 SINCO PHARMA
- 0.212
- 0.0000.00%
Not Open Sep 13 16:08 CST
430.97MMarket Cap8.48P/E (TTM)
0.212High0.212Low80.00KVolume0.212Open0.212Pre Close16.96KTurnover0.00%Turnover Ratio9.22P/E (Static)2.03BShares0.31652wk High0.61P/B430.97MFloat Cap0.19052wk Low0.00Dividend TTM2.03BShs Float2.306Historical High0.004Dividend LFY0.00%Amplitude0.132Historical Low0.212Avg Price4000Lot Size1.89%Div YieldTTM1.89%Div Yield LFY
SINCO PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 40.06%1.53B | 11.82%2.54B | -3.52%1.09B | 12.23%2.27B | 33.40%1.13B | -1.26%2.02B | 33.12%847.04M | 74.24%2.05B | 18.84%636.31M | 23.45%1.18B |
| Operating income | 40.06%1.53B | 11.82%2.54B | -3.52%1.09B | 12.23%2.27B | 33.40%1.13B | -1.26%2.02B | 33.12%847.04M | 74.24%2.05B | 18.84%636.31M | 23.45%1.18B |
| Cost of sales | -44.38%-1.35B | -12.78%-2.22B | 0.02%-937.58M | -18.48%-1.97B | -36.00%-937.73M | 6.58%-1.66B | -30.66%-689.52M | -85.66%-1.78B | -18.72%-527.73M | -30.69%-956.56M |
| Operating expenses | -44.38%-1.35B | -12.78%-2.22B | 0.02%-937.58M | -18.48%-1.97B | -36.00%-937.73M | 6.58%-1.66B | -30.66%-689.52M | -85.66%-1.78B | -18.72%-527.73M | -30.69%-956.56M |
| Gross profit | 13.55%173.21M | 5.69%323.28M | -20.63%152.55M | -16.19%305.87M | 22.01%192.2M | 33.28%364.95M | 45.08%157.53M | 24.55%273.83M | 19.41%108.58M | -0.53%219.85M |
| Selling expenses | 22.57%-36.47M | 19.91%-93.71M | 30.50%-47.1M | -11.05%-117.02M | -94.32%-67.77M | -17.30%-105.38M | 43.14%-34.87M | 21.57%-89.84M | -37.91%-61.33M | 57.35%-114.54M |
| Administrative expenses | -26.38%-61.19M | -33.70%-108.86M | -29.71%-48.42M | -23.37%-81.42M | -114.21%-37.33M | -62.76%-66M | 13.50%-17.43M | 11.47%-40.55M | 4.11%-20.15M | 17.46%-45.81M |
| Revaluation surplus | -32.61%-1.78M | -13.94%-3M | -171.86%-1.34M | ---2.63M | ---494K | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of other assets | -32.61%-1.78M | -13.94%-3M | -171.86%-1.34M | ---2.63M | ---494K | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | -459.79%-4.23M | 28.37%-4.25M | 87.12%-756K | -592.29%-5.93M | -15,550.00%-5.87M | -383.44%-856K | -98.32%38K | 123.74%302K | 140.13%2.26M | 94.95%-1.27M |
| -Other impairment is provision | -459.79%-4.23M | 28.37%-4.25M | 87.12%-756K | -592.29%-5.93M | -15,550.00%-5.87M | -383.44%-856K | -98.32%38K | 123.74%302K | 140.13%2.26M | 13.88%-1.27M |
| Special items of operating profit | 220.60%5.79M | -95.44%855K | -150.81%-4.8M | 389.30%18.76M | 659.41%9.45M | 278.75%3.83M | -38.39%1.24M | -78.68%1.01M | -83.42%2.02M | 104.36%4.75M |
| Operating profit | 50.28%75.33M | -2.81%114.32M | -44.42%50.13M | -40.16%117.63M | -15.33%90.19M | 35.78%196.55M | 239.41%106.51M | 129.83%144.75M | -1.94%31.38M | 126.55%62.98M |
| Financing cost | 0.29%-7.34M | 21.27%-14.43M | 36.64%-7.36M | 37.14%-18.33M | 21.64%-11.62M | -231.52%-29.16M | -1,120.16%-14.83M | 56.07%-8.8M | 88.10%-1.22M | 42.48%-20.03M |
| Earning before tax | 58.98%67.99M | 0.59%99.88M | -45.56%42.77M | -40.68%99.29M | -14.31%78.57M | 23.12%167.39M | 203.93%91.68M | 216.51%135.96M | 38.44%30.17M | 115.79%42.96M |
| Tax | -90.40%-44.12M | -92.86%-57.53M | -39.22%-23.17M | 7.66%-29.83M | -1.48%-16.65M | -81.30%-32.3M | -817.54%-16.4M | 8.18%-17.82M | 134.72%2.29M | -125.64%-19.41M |
| After-tax profit from continuing operations | 21.82%23.87M | -39.03%42.35M | -68.36%19.6M | -48.58%69.46M | -17.74%61.92M | 14.34%135.08M | 131.98%75.28M | 401.64%118.14M | 113.42%32.45M | 108.39%23.55M |
| Earning after tax | 21.82%23.87M | -39.03%42.35M | -68.36%19.6M | -48.58%69.46M | -17.74%61.92M | 14.34%135.08M | 131.98%75.28M | 401.64%118.14M | 113.42%32.45M | 108.39%23.55M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.00%-2K |
| Profit attributable to shareholders | 21.82%23.87M | -39.03%42.35M | -68.36%19.6M | -48.58%69.46M | -17.74%61.92M | 14.34%135.08M | 131.98%75.28M | 401.60%118.14M | 113.40%32.45M | 108.39%23.55M |
| Basic earnings per share | 20.62%0.0117 | -38.24%0.021 | -68.20%0.0097 | -56.41%0.034 | -31.46%0.0305 | 11.43%0.078 | 134.21%0.0445 | 400.00%0.07 | 111.11%0.019 | 108.43%0.014 |
| Diluted earnings per share | 20.62%0.0117 | -38.24%0.021 | -68.20%0.0097 | -56.41%0.034 | -31.46%0.0305 | 11.43%0.078 | 134.21%0.0445 | 400.00%0.07 | 111.11%0.019 | 108.43%0.014 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Pioneer Accountants Ltd | -- | Pioneer Accountants Ltd | -- | Ernst & Young | -- | Ernst & Young | -- | Guofi Haohua (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data